Kaken Pharmaceutical Co., Ltd. (KKPCF)

USD 24.01

(0.0%)

Annual Balance Sheets

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 1.13 Billion 1.25 Billion 1.35 Billion 1.49 Billion 1.47 Billion 1.42 Billion
Total Current Assets 706.77 Million 827.23 Million 908.68 Million 1.02 Billion 1 Billion 937.17 Million
Cash And Short Term Investments 431.59 Million 558.95 Million 613.03 Million 699.59 Million 679.18 Million 529.02 Million
Cash and Cash Equivalents 431.59 Million 558.95 Million 613.03 Million 699.59 Million 679.18 Million 529.02 Million
Short Term Investments 14.69 Billion 14.69 Billion 13.59 Billion 13.59 Billion 13.59 Billion 11.59 Billion
Net Receivables 156.87 Million 145.03 Million 166.43 Million 185.96 Million 201.93 Million 274.11 Million
Inventory 113.42 Million 117.14 Million 123.06 Million 137.52 Million 113.69 Million 123.94 Million
Other Current Assets 4.88 Million 6.11 Million 6.15 Million 5.52 Million 8.71 Million 10.09 Million
Total Non-Current Assets 427.13 Million 424.71 Million 448.27 Million 470.17 Million 472.71 Million 491.25 Million
Net PPE 167.52 Million 191.92 Million 211.4 Million 226.42 Million 236.37 Million 238.53 Million
Good Will And Intangible Assets 7.46 Billion 6.74 Billion 8.23 Billion 625 Million 414 Million 551 Million
Good Will - - - - 410.16 Million 546.02 Million
Intangible Assets 7.46 Billion 6.74 Billion 8.23 Billion 625 Million 3.83 Million 4.97 Million
Long-Term Investments 135.65 Million 131.8 Million 140.41 Million 157.17 Million 139.28 Million 154.2 Million
Tax Assets 17.11 Million 29.15 Million 14.17 Million 34.94 Million 43.74 Million 45.67 Million
Other Non Current Assets -7.35 Billion -6.66 Billion -8.15 Billion -573.37 Million -360.68 Million -498.14 Million
Other Assets - -0.00 - 1.00 - -
Total Liabilities 184.11 Million 221.96 Million 220.6 Million 265.67 Million 286.21 Million 334.04 Million
Total Current Liabilities 125.69 Million 156.84 Million 156.48 Million 192.54 Million 200.59 Million 249.17 Million
Account Payables 46.9 Million 46.81 Million 48.78 Million 77.54 Million 80.42 Million 110.74 Million
Tax Payables 502.13 Thousand 15.08 Million 20.01 Million 20.74 Million 26.9 Million 36.51 Million
Short Term Debt 25.43 Million 28.97 Million 31.62 Million 34.84 Million 35.66 Million 35 Million
Deferred Revenue 284.1 Thousand 15.08 Million 20.01 Million 20.74 Million 26.9 Million 36.51 Million
Other Current Liabilities 53.06 Million 65.97 Million 56.05 Million 59.41 Million 57.6 Million 66.9 Million
Total Non Current Liabilities 58.41 Million 65.11 Million 64.11 Million 73.13 Million 85.61 Million 84.87 Million
Long-Term Debt - - - - - -
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 45.55 Million 51.78 Million 45.8 Million 52.46 Million 71.78 Million 65.7 Million
Other Liabilities - - - 1.00 1.00 -0.00
Total Equity 949.78 Million 1.02 Billion 1.13 Billion 1.23 Billion 1.19 Billion 1.09 Billion
Stock Holders Equity 949.78 Million 1.02 Billion 1.13 Billion 1.23 Billion 1.19 Billion 1.09 Billion
Common Stock 157.59 Million 179.54 Million 195.95 Million 215.86 Million 220.95 Million 215.5 Million
Retained Earnings 849.03 Million 949.41 Million 1.03 Billion 1.1 Billion 1.06 Billion 985.29 Million
Accumulated other comprehensive income 56.47 Million 36.79 Million 39.85 Million 43.78 Million 15.85 Million 32.47 Million
Common Stock Equity 949.78 Million 1.02 Billion 1.13 Billion 1.23 Billion 1.19 Billion 1.09 Billion
Capital Lease Obligation - - - - - -
Total Investments 135.65 Million 131.8 Million 140.41 Million 157.17 Million 139.28 Million 154.2 Million
Total Debt 25.43 Million 28.97 Million 31.62 Million 34.84 Million 35.66 Million 35 Million
Net Debt -406.15 Million -529.97 Million -581.4 Million -664.75 Million -643.51 Million -494.01 Million

Balance Sheet Charts